UK Markets closed
NIKKEI 225
26,871.27 +379.30 (+1.43%) HANG SENG
22,229.52 +510.46 (+2.35%) CRUDE OIL
108.97 +1.35 (+1.25%) GOLD FUTURES
1,826.40 -3.90 (-0.21%) DOW
31,515.74 +15.06 (+0.05%) BTC-GBP
16,843.30 -556.96 (-3.20%)
Adverum Biotechnologies, Inc. (0HA3.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 04:59PM BST
| Previous close | 1.0800 |
| Open | 1.0400 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 1.0400 - 1.0600 |
| 52-week range | 1.0400 - 1.0600 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 84.267M |
| Beta (5Y monthly) | 1.21 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
How Much Of Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Do Institutions Own?
A look at the shareholders of Adverum Biotechnologies, Inc. ( NASDAQ:ADVM ) can tell us which group is most powerful...
- Zacks
Adverum (ADVM) Up on FDA Feedback for Gene Therapy Study
Adverum (ADVM) to submit IND amendment to the FDA by mid-2022 for starting a mid-stage study on its gene therapy candidate ADVM-022 for treating wet AMD eye disorder.
- Zacks
Should You Buy Adverum Biotechnologies (ADVM) Ahead of Earnings?
Adverum Biotechnologies (ADVM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
© 2022 Yahoo. All rights reserved.
